サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1765310

全エクソーム・シーケンスの世界市場

Whole Exome Sequencing

出版日
ページ情報
英文 194 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.69円
全エクソーム・シーケンスの世界市場
出版日: 2025年07月09日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

全エクソーム・シーケンスの世界市場は2030年までに74億米ドルに到達

2024年に24億米ドルと推定される全エクソーム・シーケンスの世界市場は、2024年から2030年にかけてCAGR 20.2%で成長し、2030年には74億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるシステムは、CAGR 21.3％を占め、分析期間終了時には41億米ドルに達すると予測されます。キットセグメントの成長率は、分析期間でCAGR 18.3％と推定されます。

米国市場は6億7,730万米ドルと推定、中国はCAGR18.8％で成長予測

米国の全エクソーム・シーケンス市場は、2024年に6億7,730万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに11億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは18.8%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ18.5％と17.1％と予測されています。欧州では、ドイツがCAGR約14.3%で成長すると予測されています。

世界の全エクソーム・シーケンス市場- 主要動向と促進要因まとめ

ゲノム調査における全エクソーム・シーケンス採用の原動力は？

全エクソーム・シーケンス（WES）は、エクソームとして知られるゲノムのタンパク質コード領域に対する包括的な洞察を提供する能力により、ゲノム研究および臨床診断において急速に重要性を増しています。この方法により、研究者は希少遺伝性疾患、がん、神経疾患などの疾患に関連する遺伝子変異を同定することができ、精密医療のための強力なツールとなります。個別化医療への注目の高まりと遺伝性疾患の有病率の上昇が、臨床および研究現場におけるWESの採用を後押ししています。全ゲノムシーケンスと比較して、WESはエクソームを研究するためのコスト効率の高いアプローチを提供し、疾患の遺伝的基盤の理解と標的療法の開発に大きな利点をもたらします。

技術の進歩はどのように全エクソーム・シーケンスを強化しているか？

次世代シーケンサー（NGS）とバイオインフォマティクスの技術的進歩は、全エクソーム・シーケンスの効率性、正確性、費用対効果を大幅に向上させています。ハイスループットシーケンスプラットフォームの開発、ターゲット濃縮技術の向上、ライブラリー調製法の最適化により、エクソームのシーケンスがより迅速かつ正確に行えるようになっています。バイオインフォマティクスツールとソフトウェアの革新により、データ解析と解釈が改善され、研究者はより高い精度で臨床的に関連する遺伝子変異を同定できるようになっています。さらに、ゲノムデータ解析における人工知能（AI）と機械学習（ML）の統合は、疾患リスク、治療効果、患者の転帰の予測を可能にし、臨床診断と精密医療におけるWESの応用をさらに拡大しています。

全エクソーム・シーケンス市場の課題と機会とは？

全エクソーム・シーケンス市場は、シーケンスの高コスト、バイオインフォマティクスの専門知識の必要性、遺伝子データのプライバシーに関する倫理的懸念など、いくつかの課題に直面しています。さらに、検出されたバリアントの多くは臨床的意義が不確実または不明である可能性があるため、遺伝子バリアントの解釈は依然として大きな課題となっています。しかし、これらの課題は成長と革新の機会にもなります。ユーザーフレンドリーなバイオインフォマティクスツールとともに、より費用対効果が高くスケーラブルなシークエンシングプラットフォームが開発されれば、導入の障壁を下げ、臨床現場におけるWESの使用を拡大することができます。希少疾患研究、がんゲノミクス、個別化医療への重点の高まりは、実用的な遺伝子変異を同定するための重要なツールとして、WESに新たな成長機会をもたらしています。さらに、共同研究ネットワークやゲノムデータベースの台頭により、既存のヘルスケアや研究インフラと統合できる堅牢で相互運用可能なシーケンスソリューションの必要性が高まっています。

全エクソーム・シーケンス市場の成長の原動力は？

全エクソーム・シーケンス市場の成長は、個別化医療への注目の高まり、遺伝性疾患の有病率の上昇、次世代シーケンサーとバイオインフォマティクスの技術進歩など、いくつかの要因によってもたらされます。疾患の原因となる変異を同定し、標的療法を開発するための包括的なゲノムインサイトの必要性が、臨床および研究環境におけるWESの市場需要を大幅に押し上げています。ハイスループットシーケンス、ターゲットエンリッチメント、AI主導のデータ解析における技術革新は、WESの効率性、正確性、費用対効果を高め、より幅広いヘルスケアプロバイダーや研究者がWESを利用しやすくしています。疾病診断、リスク評価、治療開発のための強力なゲノムツールを利害関係者が求めているため、精密医療への取り組みの拡大と希少疾病研究および腫瘍学への重点の高まりも市場開発の促進要因となっています。

セグメント

提供（システム、キット、サービス）;アプリケーション（診断、創薬・開発、個別化医療、その他のアプリケーション）

調査対象企業の例

  • Agilent Technologies, Inc.
  • Ambry Genetics
  • BGI Europe
  • Eurofins Genomics GmbH
  • GENEWIZ, Inc.
  • Illumina, Inc.
  • Macrogen, Inc.
  • Roche Nimblegen, Inc.
  • Sengenics
  • Thermo Fisher Scientific, Inc.

AIインテグレイションズ

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP15631

Global Whole Exome Sequencing Market to Reach US$7.4 Billion by 2030

The global market for Whole Exome Sequencing estimated at US$2.4 Billion in the year 2024, is expected to reach US$7.4 Billion by 2030, growing at a CAGR of 20.2% over the analysis period 2024-2030. Systems, one of the segments analyzed in the report, is expected to record a 21.3% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth in the Kits segment is estimated at 18.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$677.3 Million While China is Forecast to Grow at 18.8% CAGR

The Whole Exome Sequencing market in the U.S. is estimated at US$677.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 18.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 18.5% and 17.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.3% CAGR.

Global Whole Exome Sequencing Market - Key Trends & Drivers Summarized

What Is Driving the Adoption of Whole Exome Sequencing in Genomic Research?

Whole exome sequencing (WES) is rapidly gaining importance in genomic research and clinical diagnostics due to its ability to provide comprehensive insights into the protein-coding regions of the genome, known as exomes. This method enables researchers to identify genetic variants associated with diseases, including rare genetic disorders, cancers, and neurological conditions, making it a powerful tool for precision medicine. The increasing focus on personalized medicine and the rising prevalence of genetic diseases are driving the adoption of WES in clinical and research settings. Compared to whole-genome sequencing, WES offers a cost-effective approach to studying the exome, providing significant advantages in understanding the genetic basis of diseases and developing targeted therapies.

How Are Technological Advancements Enhancing Whole Exome Sequencing?

Technological advancements in next-generation sequencing (NGS) and bioinformatics are significantly enhancing the efficiency, accuracy, and cost-effectiveness of whole exome sequencing. The development of high-throughput sequencing platforms, improved target enrichment techniques, and optimized library preparation methods are enabling faster and more accurate sequencing of the exome. Innovations in bioinformatics tools and software are improving data analysis and interpretation, allowing researchers to identify clinically relevant genetic variants with greater precision. Additionally, the integration of artificial intelligence (AI) and machine learning (ML) in genomic data analysis is enabling the prediction of disease risk, treatment response, and patient outcomes, further expanding the application of WES in clinical diagnostics and precision medicine.

What Are the Challenges and Opportunities in the Whole Exome Sequencing Market?

The whole exome sequencing market faces several challenges, including the high cost of sequencing, the need for specialized bioinformatics expertise, and ethical concerns related to genetic data privacy. Additionally, the interpretation of genetic variants remains a significant challenge, as many detected variants may have uncertain or unknown clinical significance. However, these challenges also present opportunities for growth and innovation. The development of more cost-effective and scalable sequencing platforms, along with user-friendly bioinformatics tools, can help lower the barriers to adoption and expand the use of WES in clinical practice. The increasing emphasis on rare disease research, cancer genomics, and personalized medicine is creating new growth opportunities for WES as a critical tool for identifying actionable genetic variants. Moreover, the rise of collaborative research networks and genomic databases is driving the need for robust and interoperable sequencing solutions that can integrate with existing healthcare and research infrastructures.

What Is Driving the Growth of the Whole Exome Sequencing Market?

The growth in the Whole Exome Sequencing market is driven by several factors, including the increasing focus on personalized medicine, rising prevalence of genetic disorders, and technological advancements in next-generation sequencing and bioinformatics. The need for comprehensive genomic insights to identify disease-causing variants and develop targeted therapies is significantly boosting market demand for WES in clinical and research settings. Technological innovations in high-throughput sequencing, target enrichment, and AI-driven data analysis are enhancing the efficiency, accuracy, and cost-effectiveness of WES, making it more accessible to a broader range of healthcare providers and researchers. The expansion of precision medicine initiatives, coupled with the growing emphasis on rare disease research and oncology, is also driving market growth as stakeholders seek powerful genomic tools for disease diagnosis, risk assessment, and therapeutic development.

SCOPE OF STUDY:

The report analyzes the Whole Exome Sequencing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Offering (Systems, Kits, Services); Application (Diagnostics, Drug Discovery & Development, Personalized Medicine, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Agilent Technologies, Inc.
  • Ambry Genetics
  • BGI Europe
  • Eurofins Genomics GmbH
  • GENEWIZ, Inc.
  • Illumina, Inc.
  • Macrogen, Inc.
  • Roche Nimblegen, Inc.
  • Sengenics
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Tariff Impact on Global Supply Chain Patterns
    • Whole Exome Sequencing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Genetic Research Propel the Use of Whole Exome Sequencing
    • Rising Prevalence of Genetic Disorders Amplifies Demand for Whole Exome Sequencing
    • Cost Reduction in Sequencing Technologies Spurs Whole Exome Sequencing Adoption
    • Clinical Applications in Personalized Medicine Enhance Whole Exome Sequencing Capabilities
    • Pharmaceutical Companies Increasing Investment in Drug Discovery Supports Market Growth
    • Consumer Interest in Ancestry and Genealogy Expands Market Reach
    • Expansion of Newborn Screening Programs Drives Whole Exome Sequencing Services
    • Research and Development in Rare Diseases Bolster Use of Exome Sequencing
    • Growing Biobanking Activities Sustain Demand for Whole Exome Sequencing
    • Integration of AI and Machine Learning in Genomic Research Transforms Market Landscape
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Whole Exome Sequencing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Whole Exome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Whole Exome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Personalized Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Personalized Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 18: USA Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 19: USA 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 22: Canada Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 23: Canada 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Canada 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • JAPAN
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Japan 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Japan 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • CHINA
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 30: China Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: China 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 32: China Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: China 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • EUROPE
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 34: Europe Recent Past, Current & Future Analysis for Whole Exome Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 35: Europe 6-Year Perspective for Whole Exome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 36: Europe Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Europe 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Europe 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • FRANCE
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 40: France Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: France 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 42: France Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: France 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • GERMANY
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 44: Germany Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Germany 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 46: Germany Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Germany 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 48: Italy Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Italy 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Italy 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 52: UK Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: UK 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 54: UK Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: UK 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Rest of Europe 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 58: Rest of Europe Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Rest of Europe 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Whole Exome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 60: Asia-Pacific Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Asia-Pacific 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 64: Rest of World Recent Past, Current & Future Analysis for Whole Exome Sequencing by Offering - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Rest of World 6-Year Perspective for Whole Exome Sequencing by Offering - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2025 & 2030
    • TABLE 66: Rest of World Recent Past, Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Rest of World 6-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery & Development, Personalized Medicine and Other Applications for the Years 2025 & 2030

IV. COMPETITION